Cargando…
Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The International AIDS Society
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113037/ http://dx.doi.org/10.1186/1758-2652-13-S4-P35 |
| _version_ | 1782205873742938112 |
|---|---|
| author | Llibre, JM Martínez, E Barreiro, P Escrig, R Ribera, E Cervantes, M Imaz, A Gutierrez, F Knobel, H Ornelas, A Zamora, FX Clotet, B |
| author_facet | Llibre, JM Martínez, E Barreiro, P Escrig, R Ribera, E Cervantes, M Imaz, A Gutierrez, F Knobel, H Ornelas, A Zamora, FX Clotet, B |
| author_sort | Llibre, JM |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3113037 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | The International AIDS Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31130372011-06-13 Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice Llibre, JM Martínez, E Barreiro, P Escrig, R Ribera, E Cervantes, M Imaz, A Gutierrez, F Knobel, H Ornelas, A Zamora, FX Clotet, B J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113037/ http://dx.doi.org/10.1186/1758-2652-13-S4-P35 Text en Copyright ©2010 Llibre et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Llibre, JM Martínez, E Barreiro, P Escrig, R Ribera, E Cervantes, M Imaz, A Gutierrez, F Knobel, H Ornelas, A Zamora, FX Clotet, B Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice |
| title | Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice |
| title_full | Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice |
| title_fullStr | Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice |
| title_full_unstemmed | Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice |
| title_short | Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice |
| title_sort | reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113037/ http://dx.doi.org/10.1186/1758-2652-13-S4-P35 |
| work_keys_str_mv | AT llibrejm reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice AT martineze reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice AT barreirop reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice AT escrigr reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice AT riberae reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice AT cervantesm reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice AT imaza reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice AT gutierrezf reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice AT knobelh reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice AT ornelasa reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice AT zamorafx reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice AT clotetb reasonsforusingandefficacyofraltegravirinsalvageregimenswithoutproteaseinhibitorsinclinicalpractice |